1. Home
  2. LSCC vs EXAS Comparison

LSCC vs EXAS Comparison

Compare LSCC & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • EXAS
  • Stock Information
  • Founded
  • LSCC 1983
  • EXAS 1995
  • Country
  • LSCC United States
  • EXAS United States
  • Employees
  • LSCC N/A
  • EXAS N/A
  • Industry
  • LSCC Semiconductors
  • EXAS Medical Specialities
  • Sector
  • LSCC Technology
  • EXAS Health Care
  • Exchange
  • LSCC Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • LSCC 9.6B
  • EXAS 11.0B
  • IPO Year
  • LSCC 1989
  • EXAS N/A
  • Fundamental
  • Price
  • LSCC $65.81
  • EXAS $68.80
  • Analyst Decision
  • LSCC Strong Buy
  • EXAS Strong Buy
  • Analyst Count
  • LSCC 12
  • EXAS 18
  • Target Price
  • LSCC $74.00
  • EXAS $72.44
  • AVG Volume (30 Days)
  • LSCC 2.0M
  • EXAS 2.9M
  • Earning Date
  • LSCC 11-03-2025
  • EXAS 11-03-2025
  • Dividend Yield
  • LSCC N/A
  • EXAS N/A
  • EPS Growth
  • LSCC N/A
  • EXAS N/A
  • EPS
  • LSCC 0.20
  • EXAS N/A
  • Revenue
  • LSCC $494,889,000.00
  • EXAS $3,082,033,000.00
  • Revenue This Year
  • LSCC $3.96
  • EXAS $16.68
  • Revenue Next Year
  • LSCC $19.60
  • EXAS $12.36
  • P/E Ratio
  • LSCC $329.18
  • EXAS N/A
  • Revenue Growth
  • LSCC N/A
  • EXAS 14.47
  • 52 Week Low
  • LSCC $34.69
  • EXAS $38.81
  • 52 Week High
  • LSCC $76.62
  • EXAS $72.81
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 43.55
  • EXAS 69.46
  • Support Level
  • LSCC $64.81
  • EXAS $66.14
  • Resistance Level
  • LSCC $68.89
  • EXAS $72.81
  • Average True Range (ATR)
  • LSCC 2.87
  • EXAS 2.18
  • MACD
  • LSCC -0.58
  • EXAS -0.10
  • Stochastic Oscillator
  • LSCC 33.76
  • EXAS 59.98

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: